<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Pharmaceutical sector on FinanClub</title>
    <link>https://finan.club/tags/pharmaceutical-sector/</link>
    <description>Recent content in Pharmaceutical sector on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 12 Aug 2023 07:18:00 +0000</lastBuildDate><atom:link href="https://finan.club/tags/pharmaceutical-sector/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>GSK</title>
      <link>https://finan.club/us/gsk/</link>
      <pubDate>Sat, 12 Aug 2023 07:18:00 +0000</pubDate>
      
      <guid>https://finan.club/us/gsk/</guid>
      <description>score:44
Chances: Approval of Jemperli for new frontline treatment in endometrial cancer. Initiation of separation of consumer healthcare business as part of restructuring plan. Positive Q2 2023 financial results with revenue increase. Growth potential from successful drugs in the pharmaceutical sector. Innovation focus through the use of AI and machine learning.</description>
    </item>
    
  </channel>
</rss>
